Sterling Pharma Solutions Ltd., an active pharmaceutical ingredient developer and manufacturer based in Northumberland, has announced it is expanding its presence in Japan, according to a 24 January report in Pharmaceutical Processing.
Sterling Pharma Solutions has been audited by the Japanese Pharmaceutical and Medical Devices Agency and recently appointed Koichi Hirayama to represent the firm in the country.
The UK firm hopes to benefit from the growing trend among Japanese pharma firms to outsource work, to better cope with cost pressures.